Navigation Links
Death Risk Higher in Obese Women with Colon Cancer

In women with colon cancer that has advanced beyond the early stage, obesity is associated with a poorer long-term outcome, according to a recent study. In addition to an increased risk of developing colon cancer, obese patients may have an increased risk of cancer recurrence, at least women. However, the influence of body weight on long-term outcomes and treatment-related side effects in colon cancer patients //has not been well documented.
The researchers found that women, but not men, who were overweight at the start of the trial had a significant increase in overall risk of death compared with women of normal weight. Obese women were also more likely to experience cancer recurrence.

Body weight had no significant influence on overall risk of death or cancer recurrence in men. It is noteworthy, the investigators say, that obese patients did not experience a higher rate of chemotherapy-related toxic side effects. On the contrary, they had lower rates of decreases in white blood cells and lower rates of any very serious toxicities compared with their normal-weight counterparts.
'"/>




Page: 1

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Among the Homeless
9. Diabetes on the Increase but Death Rate Falling
10. Drug Users and Risk of Death
11. Depression a cause for Death in Elderly
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Death Risk Higher Obese Women with Colon Cancer

(Date:5/4/2015)... Malibu Biotech Systems LLC salutes the ... is the first personal hygiene product dedicated specifically ... fresh breath appeal. KissSafe™ contains an FDA-approved active ... the mouth and oral cavity before and after ... additional wellness benefits. KissSafe’s proprietary prevent-tech will be ...
(Date:5/4/2015)... MO (PRWEB) May 04, 2015 Leonardo ... president and chief physician executive, and William C. Daniel, ... received and accepted personal invitations from the Secretary of ... Security Forum (NSF) at the Air War College, Maxwell ... to expose influential citizens to senior U.S. and international ...
(Date:5/4/2015)... 04, 2015 The University of ... launched a new initiative at UC Davis School ... of physicians committed to advancing Latino health. , ... or Preparing Students to Be Physicians, (“Prep Médico” ... provide scholarships, mentorship and internship opportunities, a residential ...
(Date:5/4/2015)... 2015 Takeda Pharmaceuticals Corp. has agreed ... thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ) that ... that a patient will develop bladder cancer. According ... of those eligible for the Actos settlement accept its ... cases currently pending in courts around the country, including ...
(Date:5/4/2015)... McNeil & Company , a ... of coverage for its Emergency Services Insurance Program ... insurance and proactive risk management to the emergency services ... to providing our customers with unparalleled service and the ... We are excited to launch over 100 new enhancements ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3
... 6 Million Americans Since Its,Inception in 1996 With ... NEWS, Va., Feb. 14 The Patient,Advocate Foundation ... services to millions of patients with life-threatening,debilitating and ... obtain access,to healthcare because of financial issues or ...
... of the worlds oceans are heavily impacted by human ... study that will appear in tomorrows peer-reviewed journal Science. ... Center in Silver Spring, Md., and co-author of the ... Ecosystems, joined a team of researchers that combined 17 ...
... Feb. 14 One of the nation,s,largest pharmacy ... Attorneys General from 29 states resolving claims of,deceptive ... that the agreement was reached with,Caremark Rx, L.L.C. ... L.L.C., formerly Advance PCS., As part of ...
... stress, a common cause of heart ... disease, ... love and Valentine,s Day. This February, which also is National Heart,Awareness month, let ... A healthy heart can be attained in a variety,of ways that encompass all ...
... University Cancer Institute researcher has found a biomarker that may ... cancer is going to come back after surgical removal. ... prostate cancer tissue samples that had been removed during surgical ... tumors showed a silencing of the gene CDH13 had a ...
... of the presidential nomination campaign, some candidates health care ... phrase socialized medicine has been used to attack health ... by the Harvard Opinion Research Program at the Harvard ... that Americans are split on whether a socialized medical ...
Cached Medicine News:Health News:Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered 2Health News:Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered 3Health News:New study shows extent of harmful human influences on global ecosystems 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark 3Health News:Healthy Heart, Healthy Home 2Health News:OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence 2Health News:Poll finds Americans split by political party over views on socialized medicine 2Health News:Poll finds Americans split by political party over views on socialized medicine 3
(Date:5/4/2015)... Calif. , May 4, 2015 Rogne ... for psoriasis, today announced that preclinical and mechanism of ... at the Society of Investigative Dermatology (SID) Annual Meeting ... in Atlanta, Georgia . ... advancing the development of RON2315, a novel, low MW ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
(Date:5/4/2015)... , May 4, 2015  Clinical Support Services, ... PharmD, has completed preliminary analysis of Pharmacologic Adverse ... Resources from Clinical Support Services, Inc. clinical staff ... with patients currently taking psychiatric medications to assess ... found that 93% of patients experienced at least ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: